{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T10:52:01Z","timestamp":1785581521948,"version":"3.56.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ajg.2026.01.004","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T04:35:55Z","timestamp":1773635755000},"page":"172-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Which quadruple therapy should be prescribed as first-line treatment for Helicobacter pylori infection? Results of a prospective study comparing concomitant and bismuth therapy"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5147-9590","authenticated-orcid":false,"given":"Omar","family":"Bahlaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Darhoua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anass","family":"Nadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Belabbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7008-8552","authenticated-orcid":false,"given":"Hanane","family":"Delsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa","family":"Khannoussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imane","family":"Benelbarhdadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8336","key":"10.1016\/j.ajg.2026.01.004_b0005","first-page":"1273","article-title":"Unidentified curved bacilli on gastric epithelium in active chronic gastritis","volume":"1","author":"Warren","year":"1983","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.ajg.2026.01.004_b0010","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajg.2026.01.004_b0015","first-page":"299","article-title":"Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline","volume":"20","author":"Hunt","year":"2011","journal-title":"J Gastrointestin Liver Dis"},{"issue":"9","key":"10.1016\/j.ajg.2026.01.004_b0020","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.ajg.2026.01.004_b0025","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht IV\/florence consensus report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.ajg.2026.01.004_b0030","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht VI\/florence consensus report","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ajg.2026.01.004_b0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2011.04937.x","article-title":"Review article: rifabutin in the treatment of refractory Helicobacter pylori infection","volume":"35","author":"Gisbert","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ajg.2026.01.004_b0040","article-title":"Adherence to European guidelines for Helicobacter pylori eradication therapy in Europe","volume":"26","author":"Nyssen","year":"2021","journal-title":"Helicobacter"},{"issue":"6","key":"10.1016\/j.ajg.2026.01.004_b0045","first-page":"523","article-title":"European registry on helicobacter pylori management (Hp-EuReg): impact of COVID-19 pandemic on H. pylori management in Europe","volume":"10","author":"Nyssen","year":"2022","journal-title":"United Eur. Gastroenterol J"},{"issue":"1","key":"10.1016\/j.ajg.2026.01.004_b0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.ajg.2026.01.004_b0055","first-page":"437","article-title":"Multidrug resistance in Helicobacter pylori clinical isolates from Bulgaria","volume":"49","author":"Boyanova","year":"2017","journal-title":"Infect Dis (Lond)"},{"issue":"1","key":"10.1016\/j.ajg.2026.01.004_b0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ajg.2009.508","article-title":"Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: systematic review and meta-analysis of efficacy and tolerability","volume":"105","author":"Luther","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ajg.2026.01.004_b0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2036.2007.03386.x","article-title":"Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori","volume":"26","author":"Fischbach","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"9862","key":"10.1016\/j.ajg.2026.01.004_b0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(12)61579-7","article-title":"Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomized trial","volume":"381","author":"Liou","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ajg.2026.01.004_b0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto consensus for the treatment of Helicobacter pylori infection in adults","volume":"151","author":"Fallone","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ajg.2026.01.004_b0085","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2036.2012.05211.x","article-title":"Meta-analysis: proton pump inhibitor co-therapy improves eradication rates in Helicobacter pylori infection","volume":"36","author":"McNicholl","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.ajg.2026.01.004_b0090","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2036.2010.04457.x","article-title":"Meta-analysis: the effects of probiotics in Helicobacter pylori eradication therapy","volume":"32","author":"Szajewska","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.ajg.2026.01.004_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111030","article-title":"The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during therapy: a meta-analysis","volume":"9","author":"Dang","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ajg.2026.01.004_b0100","article-title":"Probiotic supplementation does not improve eradication rates in Helicobacter pylori treatment: a meta-analysis","volume":"11","author":"Lu","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ajg.2026.01.004_b0105","first-page":"639","article-title":"ACG Clinical Guideline: Treatment of Helicobacter pylori infection","volume":"117","author":"Chey","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ajg.2026.01.004_b0110","article-title":"Concomitant therapy and bismuth quadruple therapy with Pylera\u00ae are equally effective in Helicobacter pylori eradication: a prospective randomized trial","volume":"25","author":"Romano","year":"2020","journal-title":"Helicobacter"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:28:50Z","timestamp":1779866930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197926000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1687197926000043"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2026.01.004","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Which quadruple therapy should be prescribed as first-line treatment for Helicobacter pylori infection? Results of a prospective study comparing concomitant and bismuth therapy","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2026.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}